Illumina was among the returning investors for the round that will help Columbia spinout Kallyope prepare a weight loss treatment for clinical trials.
Temasek led a funding round that expanded the UC-RNT Fund-backed health and wellness services platform's overall financing to approximately $390m.
The urban airborne vehicle spinout of TU Munich closed more than $240m in funding, in a Tencent-led round reportedly valuing it at up to $1bn.
UC Berkeley's Nurix Therapeutics will use the capital to prepare two protein modulation-based immuno-oncology drugs for the clinic.
Uday Kumar, whose previous spinout iRhythm is trading with a market cap of $2.6bn, has collected $145.6m in a GV-backed round for his latest venture.
The wearable defibrillator developer, founded by Stanford adjunct professor Uday Kumar, has raised more than $145m that will support the launch of its lead product.
Pliant Therapeutics has attracted $100m in a series C round led by Novartis, four years after it was founded to commercialise UC San Francisco research into fibrosis treatment.
Eli Lilly and WuXi AppTec contributed to what was reportedly a down round for T-cell oncology treatment developer Immunocore following a $320m raise in 2015.